Merck & Co., Inc.

Holdings History for Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Symbol
EVAX on Nasdaq
Investment type
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Latest Disclosed Shares Owned
63,004,142 shares
Security Ownership %
20%
Shares, Excluding Options vs Price
Value, Excluding Options

Merck & Co., Inc. ownership in Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

03 Feb 2025 - Merck & Co., Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 63,004,142 shares of Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX). This represents 20% ownership of the company. This is the first filing by Merck & Co., Inc. disclosing ownership of Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.